Breast cancer mortality among women with a brca1 or brca2 mutation in a magnetic resonance imaging plus mammography screening program

18Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Annual breast magnetic resonance imaging (MRI) plus mammography is the standard of care for screening women with inherited BRCA1/2 mutations. However, long-term breast cancer-related mortality with screening is unknown. Between 1997 and June 2011, 489 previously unaffected BRCA1/2 mutation carriers aged 25 to 65 years were screened with annual MRI plus mammography on our study. Thereafter, participants were eligible to continue MRI screening through the high-risk Ontario Breast Screening Program. In 2019, our data were linked to the Ontario Cancer Registry of Cancer Care Ontario to identify all incident cancers, vital status and causes of death. Observed breast cancer mortality was compared to expected mortality for age-matched women in the general population. There were 91 women diagnosed with breast cancer (72 invasive and 19 ductal carcinoma in situ (DCIS)) with median follow-up 7.4 (range: 0.1 to 19.2) years. Four deaths from breast cancer were observed, compared to 2.0 deaths expected (standardized mortality ratio (SMR) 2.0, p = 0.14). For the 489 women in the study, the probability of not dying of breast cancer at 20 years from the date of the first MRI was 98.2%. Annual screening with MRI plus mammography is a reasonable option for women who decline or defer risk-reducing mastectomy.

References Powered by Scopus

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies

3039Citations
N/AReaders
Get full text

Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

2044Citations
N/AReaders
Get full text

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

1257Citations
N/AReaders
Get full text

Cited by Powered by Scopus

IoMT Cloud-Based Intelligent Prediction of Breast Cancer Stages Empowered with Deep Learning

134Citations
N/AReaders
Get full text

MRI Surveillance and Breast Cancer Mortality in Women with BRCA1 and BRCA2 Sequence Variations

15Citations
N/AReaders
Get full text

From the patient to the population: Use of genomics for population screening

12Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Warner, E., Zhu, S., Plewes, D. B., Hill, K., Ramsay, E. A., Causer, P. A., … Narod, S. A. (2020). Breast cancer mortality among women with a brca1 or brca2 mutation in a magnetic resonance imaging plus mammography screening program. Cancers, 12(11), 1–12. https://doi.org/10.3390/cancers12113479

Readers' Seniority

Tooltip

Professor / Associate Prof. 13

50%

PhD / Post grad / Masters / Doc 10

38%

Researcher 3

12%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

79%

Nursing and Health Professions 4

14%

Chemistry 1

4%

Social Sciences 1

4%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 134

Save time finding and organizing research with Mendeley

Sign up for free